US-based women’s telehealth company, Midi Health, has reportedly raised $100million in Series D funding, bringing its total valuation to $1billion. New investors include Foresite Capital and Serena Ventures, with Advance Venture Partners, Google Ventures, and Emerson Collective being among those who continued their support.
“This is validation for the movement we’re leading to provide women better healthcare,” said Joanna Strober, co-founder and chief executive officer of Midi Health. “Women’s health has been treated like an afterthought for too long. This funding gives us the resources to rewrite that story at scale.”
Launched to tackle gaps in women’s healthcare, Midi has now expanded to become a scalable health platform offering insurance coverage to more than 45 million women, the company shares. With in excess of 25,000 patients looking for integrated care each week, it now relies on its proprietary AI engine to help with personalisation, streamlining of operations, and using health data to further research.
Among its customers, results include a 28 percent increase in breast cancer screening adherence, an 11 percent increase in colorectal cancer screening adherence, and an up to 13 percent lower total cost of care. Reductions in A1c and LDL levels have also been observed in patient data.
A new CFO, CMO, and CCO have now been appointed to help support the company with its next stage of growth.
“When women founders and women customers are heard, entire systems change,” said Serena Williams, managing partner at Serena Ventures. “We have been following Joanna and the team for years and are impressed by the scale they have achieved. They are delivering care that’s critical for every woman to have access to, in a space that represents billions of dollars of healthcare spend.”
Wider trend: Digital transformation in women’s health
The Scottish government has shared how the objectives set out in its Women’s Health Plan for Scotland are to be achieved across two phases. The first phase sets out priority areas to: ensure women have access to specialist menopause services for advice and support on the diagnosis and management of menopause; access to information for girls and women on menstrual health and management options; access for women to appropriate support, speedy diagnosis and best treatment for endometriosis; access to abortion and contraception services; rapid and easily accessible postnatal contraception; and to reduce inequalities in health outcomes for women’s general health, including work on cardiac disease.
Innovate UK has relaunched its Women in Innovation Awards for 2025–26, offering up to 60 awards a grant of up to £75,000, as part of a £4.5 million funding programme. Each successful application will receive a share of the funding, alongside business support, training, networking and role-modelling opportunities, Innovate UK noted. The programme is aimed at women founders and co-founders of late-stage startups, who are working on a minimum viable product, with early user interest or revenue, and has a growing team and plans to raise significant capital within the next 12 to 24 months.
A roadmap for delivery of Birmingham Women’s and Children’s NHS Foundation Trust’s latest strategy to 2030 has outlined a series of digital priorities across the next four years, covering post-go-live EPR optimisation, piloting AI, cloud migration, and a device and infrastructure refresh. For 2026-27, aims include publishing a new digital strategy, post-go-live optimisation of Epic EPR, completing a legacy system risk assessment and prioritised replacement plan, piloting AI solutions, redesigning data governance, and developing a pathology and genetics LIMS.
